G01N 2333/4715
Cytokine-induced proteins
G01N2333/4715 (Cytokine-induced proteins) appears on 20 US grants and 30 published applications in this corpus.
Search patents in G01N- Granted patents
- 20
- Published applications
- 30
- Assignees
- 25
- Inventors
- 81
- Latest grant
- 12 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 3 |
| 2004 | 0 | 1 |
| 2005 | 1 | 1 |
| 2006 | 1 | 1 |
| 2007 | 1 | 3 |
| 2008 | 0 | 1 |
| 2009 | 1 | 1 |
| 2010 | 2 | 0 |
| 2011 | 1 | 0 |
| 2012 | 1 | 2 |
| 2013 | 0 | 1 |
| 2014 | 2 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 2 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 3 |
| 2021 | 1 | 0 |
| 2022 | 0 | 2 |
| 2023 | 1 | 3 |
| 2024 | 0 | 1 |
| 2025 | 2 | 0 |
By publication year.
Recent patents
- CXCL10 binding proteins and uses thereof12 Aug 2025US 12,384,838 B2Hudson Institute of Medical Research
- Method and device for discriminating between viral and bacterial infections17 Jun 2025US 12,332,242 B2Dewact Labs GmbH
- CXCL10 binding proteins and compositions thereof15 Aug 2023US 11,725,048 B2Hudson Institute of Medical Research
- Assay for detecting TH1 and TH2 cell populations26 Oct 2021US 11,156,600 B2Amgen Inc.
- Aiding assessment of prognosis in inflammatory disease by measuring octameric PTX319 Mar 2019US 10,234,463 B2King's College London
- Cxcl10 binding proteins and uses thereof7 Mar 2024US 2024/0076366 A1Hudson Institute of Medical Research
- Esm-1 for the assessment of silent brain infarcts and cognitive decline26 Oct 2023US 2023/0341419 A1Roche Diagnostics Operations, Inc.
- Ptx3 as prognostic marker in covid-1910 Aug 2023US 2023/0251274 A1Humanitas Mirasole S.P.A.
- Cxcl10 binding proteins and uses thereof16 Feb 2023US 2023/0051580 A1Hudson Institute of Medical Research
- Method and device for discriminating between viral and bacterial infections22 Dec 2022US 2022/0404346 A1Dewact Labs GmbH
Most cited
By later US patents
- Reagents and method for modulating Dkk-mediated interactions11US 7,700,101 B2Oscient Pharmaceuticals Corporation · 2010
- Determination of pregnancy status in cattle and sheep8US 7,125,728 B2Idaho Research Foundation, Inc. · 2006
- Use of antibodies against MxA or MxB to determine levels of type I interferons in vivo6US 6,200,559 B12001
- Methods for identifying modulators of transcriptional activator protein interactions3US 6,391,572 B1The Rockefeller University · 2002
- Determination of pregnancy status in ungulate ruminants3US 8,658,431 B2Idaho Research Foundation, Inc. · 2014